Results 21 to 30 of about 5,863 (207)

Topiramate for juvenile myoclonic epilepsy. [PDF]

Cochrane Database Syst Rev, 2021
Topiramate is a newer broad-spectrum antiepileptic drug (AED). Some studies have shown the benefits of topiramate in the treatment of juvenile myoclonic epilepsy (JME). However, there are no current systematic reviews to determine the efficacy and tolerability of topiramate in people with JME.
Liu J, Tai YJ, Wang LN.
europepmc   +5 more sources

Juvenile myoclonic epilepsy [PDF]

BMJ, 2012
Diagnosed with epilepsy in her twenties, Nicola Morrison was told it was likely to be life long.
Morrison, Nicola, Thomas, Rhys Huw, Smith, Philip E. M.   +2 more
  +7 more sources

The network neuropsychology of juvenile myoclonic epilepsy. [PDF]

Cortex
Unknown in the clinical neuropsychology of Juvenile Myoclonic Epilepsy (JME) is the impact of the disorder on the nature of the relationships of specific cognitive abilities among themselves including their patterns of integration, segregation, and topographical organization-that is, the network neuropsychology of JME remains to be addressed.
Garcia-Ramos C, Struck AF, Nair VA, Prabhakaran V, Imhoff-Smith TP, Adluru N, Almane DN, Jones JE, Hermann BP.   +8 more
europepmc   +3 more sources

Juvenile myoclonic epilepsy [PDF]

Medical Journal of Australia, 1992
Abstract Juvenile myoclonic epilepsy is a relatively common, though under diagnosed, form of epilepsy that commences in adolescence. The distinguishing symptoms, diagnosis and medical management are discussed.
P L, Timmings, A, Richens
openaire   +5 more sources

Variation in prognosis and treatment outcome in juvenile myoclonic epilepsy: a Biology of Juvenile Myoclonic Epilepsy Consortium proposal for a practical definition and stratified medicine classifications. [PDF]

Brain Commun, 2023
\ua9 2023 The Author(s). Published by Oxford University Press on behalf of the Guarantors of Brain.Reliable definitions, classifications and prognostic models are the cornerstones of stratified medicine, but none of the current classifications systems in
Rubboli G, Beier CP, Selmer KK, Syvertsen M, Shakeshaft A, Collingwood A, Hall A, Andrade DM, Fong CY, Gesche J, Greenberg DA, Hamandi K, Lim KS, Ng CC, Orsini A, BIOJUME Consortium , Striano P, Thomas RH, Zarubova J, Richardson MP, Strug LJ, Pal DK.   +21 more
europepmc   +3 more sources

Headache in juvenile myoclonic epilepsy [PDF]

The Journal of Headache and Pain, 2011
The objective of this study was to assess the prevalence of and risk factors for primary headaches in juvenile myoclonic epilepsy (JME). Headache was classified in 75 patients with JME using a questionnaire, and its prevalence was correlated with the literature on the general population and clinical data. Headache was present in 47 patients. Thirty-one
Schankin, Christoph J., Rémi, Jan, Klaus, Ira, Sostak, Petra, Reinisch, Veronika M., Noachtar, Soheyl, Straube, Andreas   +6 more
openaire   +2 more sources

Lifetime prognosis of juvenile myoclonic epilepsy

, 2021
Juvenile myoclonic epilepsy (JME) is among the most common types of genetic epilepsies, displaying a good prognosis when treated with appropriate drugs, but with a well-known tendency to relapse after withdrawal.
Camfield, Peter R., Camfield, Carol S., Baykan, BETÜL, MARTINEZ-JUAREZ, Iris E., Altindag, Ebru A.   +4 more
core   +2 more sources

Juvenile myoclonic epilepsy as a spectrum disorder: A focused review

, 2021
In consequence of newer research juvenile myoclonic epilepsy (JME) is no longer seen as a homogeneous disease. The causes of the existing variance are only partially known yet.
Wolf, Peter, Baykan, BETÜL
core   +1 more source

Analysis of the tremor in juvenile myoclonic epilepsy

, 2021
Purpose: We aimed to investigate juvenile myoclonic epilepsy (JME) patients complaining of tremor unrelated to valproate (VPA) treatment and evaluate if there were differences between JME patients with and without tremor and essential tremor (ET ...
Oge, Ali Emre, Hanagasi, Haşmet Ayhan, Bilgic, Başar, Matur, Zeliha, Bebek, Nerses, Tekturk, Pinar, Aydin-Ozemir, Zeynep, Gurses, Candan, Baykan, BETÜL   +8 more
core   +1 more source

Heart rate and conductivity disorders in juvenile myoclonic epilepsy: genetic predictors

Эпилепсия и пароксизмальные состояния, 2021
General practitioners, therapists, and cardiologists do not have formal education (training) regarding cerebrocardial syndrome, primarily heart rhythm and conduction disorders in epilepsy and sudden unexpected death in epilepsy (SUDEP), as well as the ...
N. A. Shnayder, M. M. Petrova, K. V. Petrov, D. V. Dmitrenko, R. F. Nasyrova   +4 more
doaj   +1 more source